Medpace: A Shorter, Cleaner Backlog Is Being Mistaken For A Smaller One

Medpace's stock price has fallen due to concerns about its backlog. However, analysts note that the company's backlog is shorter and cleaner, not smaller, which could benefit its earnings in the long run.